Compound 661
Identifiers
- Canonical SMILES:
O=C(O)[C@H](Cc1ccccc1)N1C(=S)S\C(=C/c2ccc(OCOCCOCOc3ccc(cc3)\C=C3/SC(=S)N(C3=O)[C@H](C(=O)O)Cc3ccccc3)cc2)C1=O
- InChi:
InChI=1S/C42H36N2O10S4/c45-37-35(57-41(55)43(37)33(39(47)48)21-27-7-3-1-4-8-27)23-29-11-15-31(16-12-29)53-25-51-19-20-52-26-54-32-17-13-30(14-18-32)24-36-38(46)44(42(56)58-36)34(40(49)50)22-28-9-5-2-6-10-28/h1-18,23-24,33-34H,19-22,25-26H2,(H,47,48)(H,49,50)/b35-23-,36-24-/t33-,34-/m0/s1
- InChiKey:
VIENFBBWIGREAI-YMEGPHBOSA-N
External links
168317493 |
External search
Bibliography (1)
Publication | Name |
---|---|
Wang L, Kong F, Kokoski CL, Andrews DW, Xing C. . Development of dimeric modulators for anti-apoptotic Bcl-2 proteins. Bioorganic & medicinal chemistry letters. | D4 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
3 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 5.06 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 856.13 g/mol | |||
HBA | 12 | |||
HBD | 2 | |||
HBA + HBD | 14 | |||
AlogP | 8.97 | |||
TPSA | 152.14 | |||
RB | 19 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 3 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
18023349 | D4 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 4.67 | |
18023349 | D4 | B2CL1 Q07817 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 5.06 | |
18023349 | D4 | B2CL2 Q92843 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 4.86 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5663 | Epalrestat | DB15293 | |
0.5114 | (Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE | DB07838 | |
0.5021 | (E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID | DB08177 | |
0.4852 | (5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE | DB07503 | |
0.4823 | [(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid | DB06998 | |
0.3990 | 4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE | DB08753 | |
0.3897 | N-[(2S)-3-Phenyl-2-sulfanylpropanoyl]-L-phenylalanyl-L-tyrosine | DB03949 | |
0.3889 | Ponesimod | DB12016 | |
0.3884 | Amoxicillin | DB01060 | |
0.3825 | Carindacillin | DB09319 | |
0.3814 | (2R,4S)-2-[(1R)-1-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | DB03658 | |
0.3803 | Penamecillin | DB13739 | |
0.3799 | N-Caffeoyltyramine | DB08754 | |
0.3782 | Pivampicillin | DB01604 | |
0.3770 | 4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE | DB07540 |